0001830073-20-000002.txt : 20201117
0001830073-20-000002.hdr.sgml : 20201117
20201117140246
ACCESSION NUMBER: 0001830073-20-000002
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20201117
DATE AS OF CHANGE: 20201117
EFFECTIVENESS DATE: 20201117
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: HIVE Diversity, Inc.
CENTRAL INDEX KEY: 0001830073
IRS NUMBER: 843740986
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-379493
FILM NUMBER: 201320491
BUSINESS ADDRESS:
STREET 1: 287 PARK AVENUE SOUTH
STREET 2: SUITE 631
CITY: NEW YORK
STATE: NY
ZIP: 10010
BUSINESS PHONE: (332) 206-2760
MAIL ADDRESS:
STREET 1: 287 PARK AVENUE SOUTH
STREET 2: SUITE 631
CITY: NEW YORK
STATE: NY
ZIP: 10010
D/A
1
primary_doc.xml
X0708
D/A
LIVE
0001830073
HIVE Diversity, Inc.
287 PARK AVENUE SOUTH
SUITE 631
NEW YORK
NY
NEW YORK
10010
(332) 206-2760
DELAWARE
None
None
Corporation
true
2020
Byron
Slosar
287 Park Avenue South
Suite 631
New York
NY
NEW YORK
10010
Executive Officer
Director
Lisa
Rapkin
287 Park Avenue South
Suite 631
New York
NY
NEW YORK
10010
Director
Dakotah
Eddy
287 Park Avenue South
Suite 631
New York
NY
NEW YORK
10010
Executive Officer
Ann
Tenenbaum
287 Park Avenue South
Suite 631
New York
NY
NEW YORK
10010
Director
Other Technology
Decline to Disclose
- 06b
true
0001830073-20-000001
2020-10-21
false
true
true
Sale of Series Seed Preferred Stock and Conversion of SAFE Instruments.
false
1
2874962
2874962
0
Conversion of $874,983.66 in SAFE Instruments into Series Seed Preferred Stock and cash purchase of $1,999,978 in Series Seed Preferred Stock.
false
23
0
0
17500
false
HIVE Diversity, Inc.
Byron Slosar
Byron Slosar
CEO
2020-11-17